Appleton Partners Inc/Ma / LLY
Appleton Partners Inc/Ma’s Eli Lilly & Co Position
Does Appleton Partners Inc/Ma own Eli Lilly & Co (LLY)? Yes — 19.1K shares worth $18M (+1.22% of its 13F portfolio) as of Q1 2026, up from 18.1K shares the prior filed quarter.
Position Value
$18M
Q1 2026
Shares
19.1K
% of Portfolio
+1.22%
Quarters Held
30
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 19.1K | $18M | +1.22% |
| Q4 2025 | 18.1K | $19M | +1.28% |
| Q3 2025 | 18.2K | $14M | +0.93% |
| Q2 2025 | 4.6K | $4M | +0.26% |
| Q1 2025 | 4.7K | $4M | +0.30% |
| Q4 2024 | 4.8K | $4M | +0.28% |
| Q3 2024 | 4.9K | $4M | +0.32% |
| Q2 2024 | 4.9K | $4M | +0.34% |
| Q1 2024 | 5.1K | $4M | +0.31% |
| Q4 2023 | 5.4K | $3M | +0.25% |
| Q3 2023 | 5.5K | $3M | +0.26% |
| Q2 2023 | 6.0K | $3M | +0.24% |
| Q1 2023 | 6.1K | $2M | +0.19% |
| Q4 2022 | 6.2K | $2M | +0.22% |
| Q3 2022 | 6.5K | $2M | +0.21% |
| Q2 2022 | 6.6K | $2M | +0.20% |
| Q1 2022 | 6.5K | $2M | +0.15% |
| Q4 2021 | 6.6K | $2M | +0.14% |
| Q3 2021 | 6.7K | $2M | +0.13% |
| Q2 2021 | 6.9K | $2M | +0.14% |
| Q1 2021 | 6.2K | $1M | +0.11% |
| Q4 2020 | 6.2K | $1M | +0.10% |
| Q3 2020 | 6.1K | $899,000 | +0.10% |
| Q2 2020 | 6.2K | $1M | +0.12% |
| Q1 2020 | 6.4K | $891,000 | +0.12% |
| Q4 2019 | 4.8K | $632,000 | +0.07% |
| Q3 2019 | 5.3K | $595,000 | +0.07% |
| Q2 2019 | 5.3K | $590,000 | +0.07% |
| Q1 2019 | 5.1K | $661,000 | +0.09% |
| Q4 2018 | 5.2K | $606,000 | +0.09% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Appleton Partners Inc/Ma’s full portfolio or all institutional holders of LLY.